Größe auswählen
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 200 μL | Warenkorb auf Verfügbarkeit prüfen | € 596,00 |
Über diesen Artikel
€ 596,00
Quality Level
biological source
rabbit
conjugate
unconjugated
antibody form
serum
antibody product type
primary antibodies
clone
polyclonal
species reactivity
human
manufacturer/tradename
Upstate®
technique(s)
inhibition assay: suitable (peptide), western blot: suitable
isotype
IgG
Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich
Verwandte Kategorien
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| antibody form serum | antibody form affinity isolated antibody | antibody form serum | antibody form purified antibody |
| biological source rabbit | biological source rabbit | biological source rabbit | biological source mouse |
| species reactivity human | species reactivity mouse, human, rat, bovine | species reactivity human | species reactivity human |
| clone polyclonal | clone polyclonal | clone polyclonal | clone JBW301, monoclonal |
| conjugate unconjugated | conjugate unconjugated | conjugate unconjugated | conjugate ALEXA FLUOR™ 647 |
| technique(s) inhibition assay: suitable (peptide), western blot: suitable | technique(s) flow cytometry: suitable, western blot: suitable | technique(s) western blot: suitable | technique(s) immunocytochemistry: suitable |
General description
Immunogen
Application
Western-Blot-Analyse: Eine 1:500-Verdünnung einer repräsentativen Charge wies Histon H2A.X in rekombinantem Protein H2A und H2A.X nach.
Biochem/physiol Actions
Physical form
Analysis Note
Western-Blot-Analyse: Eine 1:1.000-Verdünnung dieses Antikörpers wies Histon H2A.X in Jurkat-Zelllysat nach.
Other Notes
Legal Information
Sie haben nicht das passende Produkt gefunden?
Probieren Sie unser Produkt-Auswahlhilfe. aus.
Ähnliches Produkt
Lagerklasse
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Analysenzertifikate (COA)
Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Verwandter Inhalt
Cancer is a complex disease manifestation. At its core, it remains a disease of abnormal cellular proliferation and inappropriate gene expression. In the early days, carcinogenesis was viewed simply as resulting from a collection of genetic mutations that altered the gene expression of key oncogenic genes or tumor suppressor genes leading to uncontrolled growth and disease (Virani, S et al 2012). Today, however, research is showing that carcinogenesis results from the successive accumulation of heritable genetic and epigenetic changes. Moreover, the success in how we predict, treat and overcome cancer will likely involve not only understanding the consequences of direct genetic changes that can cause cancer, but also how the epigenetic and environmental changes cause cancer (Johnson C et al 2015; Waldmann T et al 2013). Epigenetics is the study of heritable gene expression as it relates to changes in DNA structure that are not tied to changes in DNA sequence but, instead, are tied to how the nucleic acid material is read or processed via the myriad of protein-protein, protein-nucleic acid, and nucleic acid-nucleic acid interactions that ultimately manifest themselves into a specific expression phenotype (Ngai SC et al 2012, Johnson C et al 2015). This review will discuss some of the principal aspects of epigenetic research and how they relate to our current understanding of carcinogenesis. Because epigenetics affects phenotype and changes in epigenetics are thought to be key to environmental adaptability and thus may in fact be reversed or manipulated, understanding the integration of experimental and epidemiologic science surrounding cancer and its many manifestations should lead to more effective cancer prognostics as well as treatments (Virani S et al 2012).
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 07-627 | 04053252589430 |
Active Filters
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung


